In the largest randomized clinical trial and first of its kind to date in the United States, a team led by investigators at Beth Israel Deaconess Medical Center (BIDMC) assessed the efficacy and safety of using a drug-coated balloon in patients undergoing coronary angioplasty.
‘Rationing by inconvenience’: Health insurers count on customers not appealing denials
When Jessica (not her real name) learned in her 20s that she had severe immunodeficiency, she was prescribed subcutaneous immunoglobulin therapy (SCIg), a very expensive